DELL vs DHR: Which Is the Better Buy?
Side-by-side comparison of Dell Technologies Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Dell Technologies Inc. · Technology
$450.22
-13.0% upside to fair value
Grade D
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
DELL trades at a lower forward P/E
(35.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DELL |
DHR |
| Current Price |
$450.22 |
$195.98 |
| Fair Value Estimate |
$391.48 |
$211.54 |
| Upside to Fair Value |
-13.0%
|
+7.9%
|
| Market Cap |
$299.1B |
$138.7B |
| Forward P/E |
35.2x
|
37.8x
|
| EV / EBITDA |
22.9x
|
22.8x
|
| Price / Sales |
2.2x
|
5.6x
|
| Price / FCF |
31.7x
|
26.2x
|
| Revenue Growth YoY |
+87.5%
|
+3.7%
|
| Gross Margin |
19.2%
|
60.7%
|
| Operating Margin |
8.0%
|
21.0%
|
| Return on Equity |
-363.2%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.16%
|
3.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Dell Technologies Inc. operates in the technology sector focusing on computer hardware, delivering strong revenue and earnings growth in the most recent quarter with 87.5% and 256.3% year-over-year increases respectively. Despite these impressive growth metrics and a solid operating margin of 8.0%, the company is currently overvalued with its stock trading 13% above the fair value estimate of $39…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
DELL |
DHR |
| Zone Low |
$293.61 |
$158.66 |
| Zone High |
$332.76 |
$179.81 |
| In Buy Zone? |
No
|
No
|